Angiotensin II (Giapreza)
- Status:
- Do Not Prescribe (DNP)
- Decision Date:
- September 2022
Comments
DNP: NICE TA859 - Angiotensin II for treating vasosuppressor-resistant hypotension caused by septic or distributive shock (Terminated appraisal). ICB commissioned. (Decision date - February 2023)
Do Not Prescribe (DNP) Drug Classifications
- 5: Less cost-effective than current standard therapy
search again